AstraZeneca Partly Resumes Coronavirus Vaccine Trial After Halting It for Safety
The company said tests of its vaccine would start up again in Britain while remaining suspended in the U.S. and other countries. Pfizer, a competitor, announced an expansion of its trials.
Source: NYT Health - Category: Consumer Health News Authors: Carl Zimmer, Katie Thomas and Benjamin Mueller Tags: your-feed-science Clinical Trials Vaccination and Immunization Coronavirus (2019-nCoV) Research AstraZeneca PLC BioNTech SE Food and Drug Administration Pfizer Inc Source Type: news
More News: AstraZeneca | Clinical Trials | Coronavirus | COVID-19 | Food and Drug Administration (FDA) | Health | Pfizer | Science | UK Health | Vaccines